City of London Investment Group Plc (LON:CLIG) today provided a trading update while Zeus Capital said: What’s new Today’s pre-close statement from City of London Investment Group (CLIG) reveals: *
Dr Stephen Franklin, CEO of Evgen Pharma LON:EVG, commented: “The first patient being dosed in this Phase II trial of SFX-01 in breast cancer is another major milestone for Evgen
Commenting on the trading results, Sunil Chatrani, CEO of Elegant Hotels LON:EHG, said: “Against a backdrop of challenging market conditions, the Group has delivered a solid performance and made good
The Times Hard Brexit talk leads to ‘bloodbath’ for sterling: The pound slipped close to its lowest level against the U.S. dollar in 32 years yesterday amid fears that today
There are currently more than 20 million smart watches and more than 50 million fitness trackers sold in the market. This rise of wearable technology is just the beginning for
Columbia Threadneedle Investments’ Matthew Evans discusses how 2016 played out for them, standout investments, his view on prospects for the year, interesting sectors and stocks he likes the look of for 2017 in this exclusive interview with DirectorsTalk
Defenx plc LON:DFX is hosting a Private Investor event which will include a company presentation discussing the milestones achieved in 2016 and growth plans for 2017, including a networking session
European Metals Holdings Limited (LON:EMH) Managing Director Keith Coughlan talks to DirectorsTalk about some very encouraging results published. Keith explains the significance of the results after the completion of the
FinnAust Mining plc (LON:FAM) Managing Director Roderick Mcillree talks to DirectorsTalk about the latest Pituffik exploration and metallurgical test work update. Rod recaps the key developments of 2016, talks about
Early data is showing a “steady start” to 2017’s housing market, as well as a “window of opportunity” for first-time buyers who have more choice and negotiating power. The Rightmove statistics
© 2025 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
